Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Perrigo's Ingenol Mebutate vs Reference in Actinic Keratosis
NCT02459795Phase 3Completed
- Sponsor
- Padagis
- Start
- May 2015
- Primary completion
- Dec 2015
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 3 trial of ingenol mebutate in actinic keratosis (AK), sponsored by Padagis. Started May 2015; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02459795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02459795.